Empresa Bioqual, Inc. Other OTC
Acciones
BIOQ
US09065J1016
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Commercial and Other
82,6
%
| 54 | 81,6 % | 52 | 82,6 % | -4,06 % |
National Institutes of Health
17,4
%
| 12 | 18,4 % | 11 | 17,4 % | -10,64 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 66 | 100,0 % | 63 | 100,0 % | -5,27 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/08/03 |
Charles C Kirk
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 09/05/22 | |
Chief Operating Officer | - | - | |
Nancy A. Madden
ADM | Chief Administrative Officer | - | 01/01/03 |
Chander P. Sarma
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/94 |
Director/Board Member | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 87 | 01/01/15 | |
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/08/03 |
Director/Board Member | - | - | |
David B. Landon
BRD | Director/Board Member | 61 | 19/04/17 |
Director/Board Member | 86 | 01/01/91 | |
Director/Board Member | 68 | 01/01/92 | |
Director/Board Member | 48 | 25/07/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 599 408 | 894 416 ( 55,92 %) | 704 992 ( 44,08 %) | 55,92 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+40,80 % | 53,67 mil M | |
+35,79 % | 38,86 mil M | |
-8,05 % | 38,76 mil M | |
-8,98 % | 27,27 mil M | |
+10,69 % | 25,91 mil M | |
-16,21 % | 20,29 mil M | |
+31,00 % | 12,78 mil M | |
+28,51 % | 12,18 mil M | |
-1,67 % | 11,96 mil M |